Organized medicine slams Part B pay plan
Congress also critical of plan to reduce pay for Part B drugs
Washington—An Obama administration plan to reform Medicare Part B payment policy has generated a chorus of bipartisan opposition from influential lawmakers and many in the medical community, including a leading oncologist who told Congress the initiative is simply an effort to cut costs by blaming physicians for prescribing more expensive drugs for profit.
In all, the Centers for Medicare & Medicaid Services (CMS) received more than 1,300 comments regarding the proposal by its May 9 deadline and is being pressured to ditch it. The leadership of the House Energy and Commerce Health Subcommittee termed it an “alarming Medicare drug experiment” during a hearing May 17 held to consider legislation that would prevent its implementation by CMS.